Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Advancing Biomarkers R&D

Experience groundbreaking in-person events, engaging online activities, and cutting-edge digital services that unite influential and passionate leaders with scientific experts, collectively shaping the future of biomarkers and precision medicine.

In-Person & Online Events

Collaborate & Partner for a Better Future

Sapient Webinar Laptop Image

Featured Webinar

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient. Sponsored by Sapient.

Explore Biomarkers & Precision Medicine

Unite with the biomarkers and precision medicine industry and healthcare sectors with thought leaders across the UK, EU, and USA with our leading Biomarkers & Precision Medicine UK & US as well as Biomarkers & Precision Oncology EU congresses. Immerse yourself in cutting-edge scientific content – from online Monthly Science Exchanges, best practice e-symposiums to eBooks and landscape reports offering unparalleled opportunities in biomarkers innovation across the value chain of discovery, translation and clinical development. 

Resources & Announcements

Diagnostic Development

Imaging Starts Using Brand New Radiotracer from Nuclidium

21/10/24 - The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer.

GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease

01/10/24 - GHR’s total investment in C2N has now broken $50 million since 2020.

Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality

06/09/24 - The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.

Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy

27/08/24 - SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.

Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma

21/08/24 - The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.

Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions

23/07/24 - Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.
Show All Resources

Online Activities

This year's suite of Biomarkers Online Activities will be revealed here shortly.

Please enjoy a selection of recordings from 2023's Monthly Science Exchanges

Biomarker Qualification Submissions at the FDA: Nephrotoxicity Biomarkers as an Example

31/10/2023 - Led by Steven Piccoli, Head of Clinical Biomarkers, SPARC

Downstream Bioprocessing: Optimising AAV Production

03/10/2023 - Led by Aline Hughson: Senior Expert at Novartis; Lea Arnaud: DSP Expert in Process Development at Novartis; & Elissa Hudspeth: Assistant Director, Downstream at the Biomanufacturing Training and Education Center, North Carolina State University

Single Cell MultiOmics and the Tumour Microenvironment

22/06/2023 - Led by Amit Grover, Associate Principal Scientist, AstraZeneca

Genomic Strategies for Immuno-oncology

15/03/2023 - Led by Zsuzsanna Izsvák, Group Leader, Max Delbrueck Center for Molecular Medicine and Pramod Srivastava, Professor Immunology, University of Connecticut

Show All Online Activities

Oxford Global PLUS Pass

Introducing the PLUS Pass – your exclusive 12-month, all-access gateway to over 40 prestigious events hosted annually across the UK, Europe, and the US.

Tailored for experts, thought-leaders, and scientists from global pharma & biotech, the PLUS Pass not only grants you entry to our curated event experiences but also offers boundless knowledge sharing through our robust PLUS Platform. Immerse yourself in a wealth of on-demand event recordings, content articles, and industry news, while engaging in thought-provoking exclusive webinars and stimulating group discussions each month.

More Info
Oxford Global PLUS

Services

Driving impact, awareness, and business generation

Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Our Services

  • In-Person Services

    At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.

  • Digital Marketing Services

    Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers